Kythera Biopharmaceuticals Inc (KYTH) Financial Statements (2024 and earlier)

Company Profile

Business Address 27200 WEST AGOURA ROAD
CALABASAS, CA 91301
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

6/30/2015
Q2
3/31/2015
Q1
12/31/2014
Q4
9/30/2014
Q3
6/30/2014
Q2
3/31/2014
Q1
12/31/2013
Q4
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments211,66899,661117,442134,688151,399167,058
Cash and cash equivalents165,87029,22639,73683,61293,169111,518
Short-term investments45,79870,43577,70651,07658,23055,540
Restricted cash and investments      5,062
Inventory, net of allowances, customer advances and progress billings     
Inventory      
Prepaid expense and other current assets1,156
Other undisclosed current assets1,2781,4981,6422,3133,703 
Total current assets:212,946101,159119,084137,001155,102173,276
Noncurrent Assets
Property, plant and equipment1,9421,8471,86584010894
Regulated entity, other noncurrent assets  29,230   736
Other noncurrent assets413420787917431 
Prepaid expense and other noncurrent assets37
Other undisclosed noncurrent assets  (29,230)   (736)
Total noncurrent assets:2,3552,2672,6521,757539131
TOTAL ASSETS:215,301103,426121,736138,758155,641173,407
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities13,39911,6519,2376,7967,3429,533
Interest and dividends payable      
Employee-related liabilities2,8854,8583,2472,3191,2393,114
Accounts payable7,4144,6903,0402,1873,2443,228
Accrued liabilities3,1002,1032,9502,2902,8593,191
Debt 4,5185,4845,9115,7805,6525,526
Other liabilities621637137   
Other undisclosed current liabilities 9982,8572,1381,4026602,522
Total current liabilities:19,53620,62917,42313,97813,65417,581
Noncurrent Liabilities
Long-term debt and lease obligation24,39622,66123,48824,84226,1635,979
Long-term debt, excluding current maturities24,39622,66123,48824,84226,1635,979
Liabilities, other than long-term debt69969857144668
Deferred revenue and credits      8
Other liabilities6996985714466 
Total noncurrent liabilities:25,09523,35924,05925,28826,1695,987
Total liabilities:44,63143,98841,48239,26639,82323,568
Equity
Equity, attributable to parent170,67059,43880,25499,492115,818149,839
Additional paid in capital507,335367,329363,912360,628357,472322,052
Accumulated other comprehensive income (loss)(15)(53)(43)884
Accumulated deficit(336,650)(307,838)(283,615)(261,144)(241,662)(172,217)
Total equity:170,67059,43880,25499,492115,818149,839
TOTAL LIABILITIES AND EQUITY:215,301103,426121,736138,758155,641173,407

Income Statement (P&L) ($ in thousands)

6/30/2015
Q2
3/31/2015
Q1
12/31/2014
Q4
9/30/2014
Q3
6/30/2014
Q2
3/31/2014
Q1
12/31/2013
Q4
Revenues
(Revenue, Net)
      
Cost of revenue
(Cost of Goods and Services Sold)
      
Gross profit:      
Operating expenses(27,762)(23,157)(21,311)(18,326)(68,858)(13,564)
Other undisclosed operating income      
Operating loss:(27,762)(23,157)(21,311)(18,326)(68,858)(13,564)
Nonoperating income (expense)
(Investment Income, Nonoperating)
(217)8541251(198)40
Interest and debt expense(1,079)(1,124)(1,172)(1,207)(654)(494)
Loss from continuing operations before income taxes:(29,058)(23,427)(22,471)(19,482)(69,710)(14,018)
Other undisclosed income from continuing operations      24,240
Income (loss) from continuing operations:(29,058)(23,427)(22,471)(19,482)(69,710)10,222
Income (loss) before gain (loss) on sale of properties:(29,058)(23,427)(22,471)(19,482)(69,710)10,222
Net income (loss):(29,058)(23,427)(22,471)(19,482)(69,710)10,222
Other undisclosed net income (loss) attributable to parent 246(796)  265(24,240)
Net loss available to common stockholders, diluted:(28,812)(24,223)(22,471)(19,482)(69,445)(14,018)

Comprehensive Income ($ in thousands)

6/30/2015
Q2
3/31/2015
Q1
12/31/2014
Q4
9/30/2014
Q3
6/30/2014
Q2
3/31/2014
Q1
12/31/2013
Q4
Net income (loss):(29,058)(23,427)(22,471)(19,482)(69,710)10,222
Other undisclosed comprehensive income (loss)  (57)   4
Comprehensive income (loss):(29,058)(23,484)(22,471)(19,482)(69,710)10,226
Other undisclosed comprehensive income (loss), net of tax, attributable to parent284(749)(50) 273(24,254)
Comprehensive loss, net of tax, attributable to parent:(28,774)(24,233)(22,521)(19,482)(69,437)(14,028)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: